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Equine influenza is a cause of epizootic respiratory disease of the equine. The detection of equine influenza
virus using real-time Light Cycler reverse transcription (RT)-PCR technology was evaluated over two influenza
seasons with the analysis of 171 samples submitted for viral respiratory disease. Increased sensitivity was
found in overall viral detection with this system compared to Directigen Flu A and virus isolation, which were
40% and 23%, respectively, that of the RT-PCR. The assay was also evaluated as a viable replacement for the
more traditional methods of quantifying equine influenza virus, 50% egg infectious dose and 50% tissue culture
infectious dose. There was a significant positive correlation (P < 0.05) between the quantitative RT-PCR and
both of these assays.
Equine influenza is considered the most economically im-
portant respiratory disease of the equine in countries with
substantial breeding and racing industries. Equine influenza
virus belongs to the Orthomyxoviridae family and there are two
distinct subtypes, H7N7 (11) and H3N8 (13). It is generally
accepted that the former is no longer in circulation as the last
confirmed outbreak caused by this virus was in 1978 (14),
however, outbreaks caused by H3N8 viruses occur annually. A
study conducted in Colorado in 1998 showed that the pathogen
was responsible for two-thirds of equine viral respiratory in-
fections (7).
It is imperative to have specific and sensitive virus detection
systems available for rapid diagnosis of equine influenza. Tra-
ditionally, the gold standard has been virus isolation from
nasopharyngeal swabs using embryonated hen eggs. Other di-
agnostic tests employed include virus culture in Madin Darby
canine kidney cells or measurement of a rise in antibody titer
in paired sera by hemagglutination inhibition assay (9). These
established techniques are time consuming and laborious. Fur-
thermore, the sensitivity of virus isolation is dependant on the
presence of infectious particles and some virus strains are
difficult to isolate (8). Serology provides only retrospective
data which do not facilitate prompt intervention and appropri-
ate case management. In recent years enzyme-linked immu-
nosorbent assays such as Directigen FluA (Becton Dickson)
and reverse transcription (RT)-PCR have been introduced in
some laboratories to provide more timely results although the
sensitivity of the former has been shown to be quite variable (6,
10, 12).
The Light Cycler PCR system from Roche Molecular Bio-
chemicals, allows for high-speed thermal cycling and quantita-
tive RT-PCR (qRT-PCR) using SYBR Green I dye which
binds specifically to double-stranded DNA. The aim of this
study was to transfer our most sensitive tool for equine influ-
enza virus detection (10) to a more rapid, real-time RT-PCR
system suitable for routine diagnostics using the Light Cycler
technology. The advantages of this system include faster result
turnaround time, a closed system less prone to contamination
and the elimination of gel electrophoresis. We also sought to
examine real-time RT-PCR as a viable replacement for the
more traditional methods of quantifying equine influenza vi-
rus, i.e., the determination of 50% egg infectious dose (EID50)
or tissue culture infectious dose (TCID50).
MATERIALS AND METHODS
Samples. A total of 171 nasopharyngeal swabs collected from suspect cases of
viral respiratory disease during a 2-year period were tested for the presence of
equine influenza virus. Some of these diagnostic samples were accompanied by
sera for hemagglutination inhibition testing. The second set of samples used to
validate the qRT-PCR system were previously described (10). Briefly, nasopha-
ryngeal swabs from four seronegative foals exposed to an aerosol of influenza
strain A/Equi/Kildare/89 at 106 EID50/ml were collected for 10 consecutive days
postchallenge.
Virus isolation, Directigen Flu A, and hemagglutination inhibition. Virus
isolation in embryonated eggs was carried out as previously described (10). The
immunoassay Directigen Flu A for the detection of nucleoprotein was carried
out in accordance with the manufacturer’s instructions (10). The hemagglutina-
tion inhibition assay for the measurement of antibodies to type 1 and type 2
equine influenza viruses was adapted from the Office International des
Epizooties (OIE) Manual of Standards for Diagnostic Tests and Vaccines (9).
Seroconversion was defined as a fourfold or greater rise in antibody titer.
PCR primers. Primers M52C (5-CTTCTAACCGAGGTCGAAACG-3) and
M253R (5-AGGGCATTTTGGACAAAGCGTCTA-3) designed by Fouchier
et al. (4) were used to amplify a 244-bp amplicon from nucleotides 32 to 276 of
the matrix gene. A second primer set was designed to confirm the samples
positive only by RT-PCR. A 373-bp region of the hemagglutinin gene (nucleo-
tides 566 to 938) was amplified using primer HA3F (5-GAATGTGACAATG
CCTAAC-3) and primer HA3R (5-GATGCTTCCATTTGGTGTA-3).
RT-PCR. One-step RT-PCR was performed using the Light Cycler RNA
amplification kit, SYBR Green I (Roche). RNA was extracted and purified from
100 l of nasal secretions using the RNAgents Total RNA isolation system
(Promega Corporation, Madison, Wisconsin) according to the manufacturer’s
recommendations. A 10 l RT-PCR mix consisted of 6.0 mM MgCl2, 2.0 l of 5X
reaction mix, 0.2 l enzyme mix, and 1.5 l of RNA. Primers were used at a final
concentration of 0.5 M. Reverse transcription was carried out at 55°C for 10
min, followed by an initial denaturation step at 95°C for 30 seconds. cDNA was
then amplified with 40 to 50 cycles of 95°C held for 0 seconds, 65°C for 5 seconds
(secondary target temperature 55°C), and 72°C for 10 seconds. Fluorescence
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data were acquired at the end of each cycle in a single step. Once the plateau
phase of the PCR had been reached, amplification was stopped and a standard
melting curve analysis was performed (95°C held for 0 seconds, 65°C for 10
seconds, and a 0.1°C/second rise to 95°C) with continual fluorescence measure-
ment. A second independent RT-PCR protocol was carried out with hemagglu-
tinin (HA) gene primers for validation purposes. RT-PCR conditions used with
the second primer set were the same as those used with the Matrix primers
except the 65°C annealing temperature was held for 17 seconds.
qRT-PCR. For quantification of virus shedding, purified viral genomic RNA
was used as a standard. The concentration of the standard nucleic acid was
determined by measuring the absorbance at 260 nm. Serial log dilutions of the
RNA were used to generate a standard curve ranging from 5  107 to 500
genome copies/l of viral RNA. The standard curve is the linear regression line
through the data points on a plot of Ct (threshold cycle) versus logarithm of
standard sample concentration. The crossing points of unknown samples were
determined from the regression line and the corresponding concentrations cal-
culated. The genome copy number was then calculated.
Statistical analysis. Microsoft SPSS 12.0.1 for Windows was used for formal
statistical testing, and the significance level was set at 0.05. The bivariate corre-
lations function was used to compute Pearson’s correlation coefficient for com-
paring the quantitative tests.
RESULTS AND DISCUSSION
One hundred and seventy-one nasopharyngeal swabs sub-
mitted over a two year period from cases of suspected viral
respiratory disease were tested for the presence of equine
influenza virus (Table 1). Virus was isolated from eight horses
and antigen was detected by Directigen Flu A in 14 swabs.
Acute and convalescent-phase sera were only available for
seven horses of which six on five different premises serocon-
verted to H3N8 equine influenza. Thirteen of the 23 unpaired
serum samples submitted to the laboratory and the acute sam-
ple from the horse that did not seroconvert had high antibody
titers to H3N8 equine influenza virus but no detectable anti-
body titers against H7N7. As all of the vaccines available dur-
ing the study period contained both H3N8 and H7N7 viruses,
these results were considered to suggest exposure to virus by
natural infection. However, while such serological results may
corroborate a diagnosis of influenza, they are not confirmatory.
The RT-PCR proved to be the most sensitive of the assays
used. Equine influenza virus nucleic acid was detected in the
nasal swabs from 35 horses on 17 different premises, i.e., the
overall detection rate was 20%, compared to 8% and 5% for
Directigen Flu A and virus isolation, respectively. Of the 35
RT-PCR-positive swabs 27 were positive by one or more of the
other diagnostic tests employed. All samples positive only by
RT-PCR were also tested with the second primer set against
the HA gene (data not shown) and there were no discrepan-
cies.
This study demonstrates that RT-PCR is effective in the
detection of virus shedding from seropositive horses. Virus was
isolated from only 15% of seropositive horses that tested pos-
itive by RT-PCR. The detection of virus shedding in subclini-
cally infected vaccinated horses is extremely important as the
introduction of such animals into an immunologically naı¨ve
population can lead to explosive virus spread and high mor-
bidity.
Vaccination remains the most effective control measure for
equine influenza. Vaccines need to be safe and efficacious.
Vaccine efficacy is measured by the reduction in clinical signs
and the decrease in virus shedding. We examined whether
qRT-PCR could viably replace the traditional methods of
quantifying equine influenza virus shedding, i.e., EID50 and
TCID50 analysis. Figure 1 shows the mean amount of virus
shed by the four horses per day postchallenge by qRT-PCR
analysis. We found a significant positive correlation (P  0.05)
between the traditional methods of viral quantification and the
qRT-PCR results. RT-PCR was not only less labor intensive
than the other two methods but was also far faster and 17%
and 29% more sensitive than virus isolation in eggs and tissue
culture, respectively.
FIG. 1. Mean and standard error of the mean of viral RNA cop-
ies/ml (log10) in nasal secretions of four foals from days 2 to 7 post-
challenge with equine influenza virus.
TABLE 1. Results for clinical samples
Premise Horseno.
Resulta
RT-PCR VI DFA
Serology
Paired Acute
1 1     
2    NA S
3     S
4    NA S
2 5     S
6     
7    NA 
8    NA S
3 9    NA S
10    NA NA
4 11     
5 12     
6 13     V
7 14    NA 
8 15    NA 
16    NA S
9 17    NA S
18    NA S
10 19    NA S
20    NA V
21    NA S
11 22    NA 
23    NA 
12 24    NA S
13 25    NA 
26    NA NA
14 27    NA NA
28    NA NA
15 29    NA V
30    NA V
16 31    NA NA
17 32    NA S
18 33    NA V
34    NA S
19 35    NA S
a VI, virus isolation; S, suspected exposure to H3N8 equine influenza by
natural infection; NA, not available; V, antibodies to H7N7 and H3N8 viruses
consistent with vaccination; DFA, Directigen Flu A.
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In conclusion, the Light Cycler RT-PCR protocol described
here for the detection of equine influenza virus has been shown
to be a more sensitive assay in the clinical diagnosis of influ-
enza virus infection than standard techniques. The RT-PCR
can also be reliably used for the quantification of equine in-
fluenza virus in vaccine efficacy studies Furthermore, the prim-
ers employed were designed to amplify a region of the matrix
gene which is highly conserved across different subtypes of
influenza A viruses (4). Thus, this RT-PCR detects influenza
virus from multiple species. Given the propensity of influenza
A viruses to cross the species (1, 15), 18 and their zoonotic
potential (2, 3, 5) this assay can be used with relative ease and
speed to aid virus surveillance that is advantageous not only to
the equine industry but also to public health.
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